132 related articles for article (PubMed ID: 19288023)
1. Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang.
Lee TY; Chang HH; Kuo JJ; Shen JJ
Int J Mol Med; 2009 Apr; 23(4):477-84. PubMed ID: 19288023
[TBL] [Abstract][Full Text] [Related]
2. Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats.
Lee TY; Chang HH; Wu MY; Lin HC
J Pharm Pharmacol; 2007 Apr; 59(4):583-90. PubMed ID: 17430643
[TBL] [Abstract][Full Text] [Related]
3. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats.
Lee TY; Chang HH; Chen JH; Hsueh ML; Kuo JJ
J Ethnopharmacol; 2007 Jan; 109(2):318-24. PubMed ID: 16989967
[TBL] [Abstract][Full Text] [Related]
4. Proteomics study on the hepatoprotective effects of traditional Chinese medicine formulae Yin-Chen-Hao-Tang by a combination of two-dimensional polyacrylamide gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry.
Sun H; Zhang A; Yan G; Han Y; Sun W; Ye Y; Wang X
J Pharm Biomed Anal; 2013 Mar; 75():173-9. PubMed ID: 23262417
[TBL] [Abstract][Full Text] [Related]
5. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.
Yang Q; Yang F; Tang X; Ding L; Xu Y; Xiong Y; Wang Z; Yang L
BMC Complement Altern Med; 2015 Apr; 15():122. PubMed ID: 25887351
[TBL] [Abstract][Full Text] [Related]
6. Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang.
Zhang H; Wang X; Hu P; Zhou W; Zhang M; Liu J; Wang Y; Liu P; Luo G
Molecules; 2016 Jan; 21(1):E126. PubMed ID: 26805802
[TBL] [Abstract][Full Text] [Related]
7. Determining the protective effects of Yin-Chen-Hao Tang against acute liver injury induced by carbon tetrachloride using 16S rRNA gene sequencing and LC/MS-based metabolomics.
Liu F; Sun Z; Hu P; Tian Q; Xu Z; Li Z; Tian X; Chen M; Huang C
J Pharm Biomed Anal; 2019 Sep; 174():567-577. PubMed ID: 31261038
[TBL] [Abstract][Full Text] [Related]
8. Yin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation.
Wang B; Sun MY; Long AH; Cao HY; Ren S; Bian YQ; Lu X; Gu HT; Liu CH; Liu P
Pharmacogn Mag; 2015; 11(42):417-25. PubMed ID: 25829784
[TBL] [Abstract][Full Text] [Related]
9. Exploration of the hepatoprotective chemical base of an orally administered herbal formulation (YCHT) in normal and CCl
Liu H; Chen M; Yin H; Hu P; Wang Y; Liu F; Tian X; Huang C
J Ethnopharmacol; 2019 Jun; 237():81-91. PubMed ID: 30904705
[TBL] [Abstract][Full Text] [Related]
10. Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis.
Lee TY; Chang HH; Lo WC; Lin HC
Int J Mol Med; 2010 Jun; 25(6):837-44. PubMed ID: 20428786
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the hepatoprotective chemical base of an orally administered herbal formulation (YCHT) in normal and CCl
Tian X; Liu H; Qiao S; Yin H; Chen M; Hu P; Wang Y; Peng H; Liu F; Pan G; Huang C
J Ethnopharmacol; 2019 May; 236():161-172. PubMed ID: 30802610
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
13. An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents.
Zhang A; Sun H; Yuan Y; Sun W; Jiao G; Wang X
Fitoterapia; 2011 Dec; 82(8):1160-8. PubMed ID: 21835230
[TBL] [Abstract][Full Text] [Related]
14. Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats.
Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Lin CC; Hsieh HY
Am J Chin Med; 2004; 32(2):195-207. PubMed ID: 15315258
[TBL] [Abstract][Full Text] [Related]
15. UPLC-G2Si-HDMS untargeted metabolomics for identification of metabolic targets of Yin-Chen-Hao-Tang used as a therapeutic agent of dampness-heat jaundice syndrome.
Sun H; Yang L; Li MX; Fang H; Zhang AH; Song Q; Liu XY; Su J; Yu MD; Makino T; Wang XJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():41-50. PubMed ID: 29502028
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats.
Cheung KF; Ye DW; Yang ZF; Lu L; Liu CH; Wang XL; Poon RT; Tong Y; Liu P; Chen YC; Lau GK
J Ethnopharmacol; 2009 Jul; 124(1):142-50. PubMed ID: 19501992
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
18. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
19. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
[TBL] [Abstract][Full Text] [Related]
20. The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
Matono T; Koda M; Tokunaga S; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2010 Jun; 25(6):875-82. PubMed ID: 20428791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
